Sanuwave (OTC:SNWV) (Alpharetta,Ga.) will begin the process of submitting its data to the FDA for approval of its dermaPace device for treating diabetic foot ulcers (DFU) and it will not make any changes to the clinical trial evaluating the device after it had a "positive" meeting with the agency earlier this month, the company said during a call on Tuesday.
In a move to perhaps boost Medtronic's (Dublin) Cardiac Rhythm and Heart Failure Division, the company is reporting its plan to acquire CardioInsight Technologies (Cleveland), a privately-held firm that has developed a new approach to improve the mapping of electrical disorders of the heart, for $93 million.
Small med-tech companies in the south often face difficulties raising funding to get products to market. Part of it stems from the location and the southern region of the U.S. not being a strong investment hub like some other regions of the country. Despite the funding challenges, International Biomedical Devices (IBMD; Mount Pleasant, South Carolina) is securing financing and pushing forward with a technology that could help treat patients suffering from cataracts.
